Albion Financial Group’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-15
| Closed | -$610 | – | 453 |
|
|
2022
Q4 | $610 | Sell |
15
-236
| -94% | -$9.6K | ﹤0.01% | 450 |
|
|
2022
Q3 | $16K | Hold |
251
| – | – | ﹤0.01% | 276 |
|
|
2022
Q2 | $15K | Hold |
251
| – | – | ﹤0.01% | 291 |
|
|
2022
Q1 | $16K | Sell |
251
-18
| -7% | -$1.15K | ﹤0.01% | 331 |
|
|
2021
Q4 | $20K | Hold |
269
| – | – | ﹤0.01% | 352 |
|
|
2021
Q3 | $30K | Buy |
269
+154
| +134% | +$17.2K | ﹤0.01% | 294 |
|
|
2021
Q2 | $19K | Buy |
+115
| New | +$19K | ﹤0.01% | 331 |
|